Compared with PDTC, the tumor proportion score of PD-L1 was elevated in ATC (7.7% vs. 60%; P = 0.006), and the amounts of CD3+ and CD8+ T cells, CD68+ and CD163+ macrophages, and S100+ dendritic cells were also elevated in ATC.320. The gene discussed is CD274; the disease is neoplasm.